Breaking News Instant updates and real-time market news.

DXC

DXC Technology

$26.46 /

+ (+0.00%)

, AEXAY

Atos

$0.00 /

+ (+0.00%)

09:40
01/07/21
01/07
09:40
01/07/21
09:40

DXC confirms takeover proposal from Atos, says board will evaluate

DXC Technology (DXC) confirmed that it received an "unsolicited, preliminary and non-binding proposal" from Atos SE (AEXAY)Wednesday night to acquire all DXC shares. The company said in a statement: "The DXC Technology board of directors, consistent with its fiduciary responsibilities, will be evaluating the proposal. Prior to receiving this proposal Wednesday night, DXC Technology had no knowledge of any such interest from Atos. We remain focused on delivering for our customers, people and shareholders as we execute our transformation journey."

DXC

DXC Technology

$26.46 /

+ (+0.00%)

AEXAY

Atos

$0.00 /

+ (+0.00%)

DXC DXC Technology
$26.46 /

+ (+0.00%)

01/06/21 Wolfe Research
DXC Technology downgraded to Peer Perform from Outperform at Wolfe Research
01/06/21 BofA
DXC Technology downgraded to Underperform from Buy at BofA
01/06/21 BofA
DXC Technology downgraded to Underperform from Buy at BofA
12/18/20 Wells Fargo
DXC Technology resumed with an Equal Weight at Wells Fargo
AEXAY Atos
$0.00 /

+ (+0.00%)

01/07/21 Barclays
Atos downgraded to Equal Weight from Overweight at Barclays
10/20/20 HSBC
Atos price target raised to EUR 100 from EUR 95 at HSBC
07/22/20 Craig-Hallum
RingCentral price target raised to $330 from $250 at Craig-Hallum
07/22/20 Morgan Stanley
RingCentral price target raised to $280 from $250 at Morgan Stanley

TODAY'S FREE FLY STORIES

Hot Stocks
EyePoint expects cash to fund planned operations through 2Q22 » 07:11
03/04/21
03/04
07:11
03/04/21
07:11
EYPT

EyePoint

$11.65 /

-0.51 (-4.19%)

The company said,"We…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYPT EyePoint
$11.65 /

-0.51 (-4.19%)

EYPT EyePoint
$11.65 /

-0.51 (-4.19%)

03/01/21
Fly Intel: Top five analyst initiations
03/01/21 Cowen
EyePoint initiated with an Outperform at Cowen
01/27/21 Cantor Fitzgerald
Cantor Fitzgerald starts EyePoint at Overweight with $22 price target
01/27/21 Cantor Fitzgerald
EyePoint initiated with an Overweight at Cantor Fitzgerald
EYPT EyePoint
$11.65 /

-0.51 (-4.19%)

  • 02
    Feb
Hot Stocks
United Natural Foods extends distribution pact with Whole Foods Market » 07:10
03/04/21
03/04
07:10
03/04/21
07:10
UNFI

United Natural Foods

$28.45 /

+0.66 (+2.37%)

, AMZN

Amazon.com

$3,005.00 /

-90.58 (-2.93%)

United Natural Foods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNFI United Natural Foods
$28.45 /

+0.66 (+2.37%)

AMZN Amazon.com
$3,005.00 /

-90.58 (-2.93%)

UNFI United Natural Foods
$28.45 /

+0.66 (+2.37%)

02/19/21
Fly Intel: Top five analyst initiations
02/19/21 Seaport Global
United Natural Foods initiated with a Neutral at Seaport Global
01/28/21 MKM Partners
United Natural Foods price target raised to $36 from $26 at MKM Partners
01/28/21 Northcoast
United Natural Foods downgraded to Neutral from Buy at Northcoast
AMZN Amazon.com
$3,005.00 /

-90.58 (-2.93%)

03/03/21 Jefferies
Google Cloud traction under Kurian 'under-appreciated,' says Jefferies
02/26/21 B. Riley Securities
Plug Power recent selloff provides relative discount, says B. Riley
02/17/21 Needham
Kornit Digital price target raised to $125 from $76 at Needham
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
UNFI United Natural Foods
$28.45 /

+0.66 (+2.37%)

AMZN Amazon.com
$3,005.00 /

-90.58 (-2.93%)

UNFI United Natural Foods
$28.45 /

+0.66 (+2.37%)

AMZN Amazon.com
$3,005.00 /

-90.58 (-2.93%)

UNFI United Natural Foods
$28.45 /

+0.66 (+2.37%)

AMZN Amazon.com
$3,005.00 /

-90.58 (-2.93%)

UNFI United Natural Foods
$28.45 /

+0.66 (+2.37%)

AMZN Amazon.com
$3,005.00 /

-90.58 (-2.93%)

Earnings
Great Panther Mining reports Q4 EPS 4c, consensus 0c » 07:10
03/04/21
03/04
07:10
03/04/21
07:10
GPL

Great Panther Mining

$0.89 /

-0.0395 (-4.25%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPL Great Panther Mining
$0.89 /

-0.0395 (-4.25%)

GPL Great Panther Mining
$0.89 /

-0.0395 (-4.25%)

10/29/20 Roth Capital
Great Panther Mining resumed with a Buy at Roth Capital
09/09/20 Alliance Global Partners
Great Panther Mining transferred with a Buy at Alliance Global Partners
07/10/20 Alliance Global Partners
Great Panther price target raised to 80c from 65c at Alliance Global
07/10/20 H.C. Wainwright
Great Panther Mining price target raised to $2 from $1.75 at H.C. Wainwright
GPL Great Panther Mining
$0.89 /

-0.0395 (-4.25%)

GPL Great Panther Mining
$0.89 /

-0.0395 (-4.25%)

Upgrade
Schneider National upgraded to Buy on 'robust' demand at BofA » 07:10
03/04/21
03/04
07:10
03/04/21
07:10
SNDR

Schneider National

$24.53 /

+0.55 (+2.29%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNDR Schneider National
$24.53 /

+0.55 (+2.29%)

SNDR Schneider National
$24.53 /

+0.55 (+2.29%)

06:58 Today BofA
Schneider National upgraded to Buy from Neutral at BofA
02/01/21 KeyBanc
Schneider National upgraded to Overweight from Sector Weight at KeyBanc
02/01/21 KeyBanc
Schneider National upgraded to Overweight from Sector Weight at KeyBanc
01/26/21 Susquehanna
Schneider National downgraded to Neutral from Positive at Susquehanna
SNDR Schneider National
$24.53 /

+0.55 (+2.29%)

Earnings
EyePoint reports Q4 EPS ($1.07), consensus (17c) » 07:10
03/04/21
03/04
07:10
03/04/21
07:10
EYPT

EyePoint

$11.65 /

-0.51 (-4.19%)

Reports Q4 revenue $7.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYPT EyePoint
$11.65 /

-0.51 (-4.19%)

EYPT EyePoint
$11.65 /

-0.51 (-4.19%)

03/01/21
Fly Intel: Top five analyst initiations
03/01/21 Cowen
EyePoint initiated with an Outperform at Cowen
01/27/21 Cantor Fitzgerald
Cantor Fitzgerald starts EyePoint at Overweight with $22 price target
01/27/21 Cantor Fitzgerald
EyePoint initiated with an Overweight at Cantor Fitzgerald
EYPT EyePoint
$11.65 /

-0.51 (-4.19%)

  • 02
    Feb
Hot Stocks
Wave Life Sciences cash runway expected into 2Q23 » 07:10
03/04/21
03/04
07:10
03/04/21
07:10
WVE

Wave Life Sciences

$10.29 /

-0.4 (-3.74%)

Wave expects that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$10.29 /

-0.4 (-3.74%)

WVE Wave Life Sciences
$10.29 /

-0.4 (-3.74%)

12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
11/20/20 Mizuho
Wave Life Sciences price target lowered to $19 from $21 at Mizuho
10/22/20 RBC Capital
Wave Life Sciences initiated with a Sector Perform at RBC Capital
09/22/20 Truist
Wave Life Sciences price target raised to $27 from $20 at Truist
WVE Wave Life Sciences
$10.29 /

-0.4 (-3.74%)

  • 23
    Sep
WVE Wave Life Sciences
$10.29 /

-0.4 (-3.74%)

Upgrade
Anthem upgraded to Buy from Hold at Truist » 07:09
03/04/21
03/04
07:09
03/04/21
07:09
ANTM

Anthem

$314.67 /

+3.15 (+1.01%)

Truist analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANTM Anthem
$314.67 /

+3.15 (+1.01%)

ANTM Anthem
$314.67 /

+3.15 (+1.01%)

01/28/21 Credit Suisse
Anthem price target lowered to $382 from $389 at Credit Suisse
01/28/21 Stephens
Anthem price target lowered to $340 from $350 at Stephens
01/26/21 Cowen
Anthem price target raised to $360 from $330 at Cowen
01/15/21 Jefferies
Anthem upgraded to Buy on more constructive commercial outlook at Jefferies
ANTM Anthem
$314.67 /

+3.15 (+1.01%)

ANTM Anthem
$314.67 /

+3.15 (+1.01%)

ANTM Anthem
$314.67 /

+3.15 (+1.01%)

ANTM Anthem
$314.67 /

+3.15 (+1.01%)

Earnings
Wave Life Sciences reports Q4 EPS (59c), consensus (61c) » 07:09
03/04/21
03/04
07:09
03/04/21
07:09
WVE

Wave Life Sciences

$10.29 /

-0.4 (-3.74%)

Reports Q4 revenue $9.4M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$10.29 /

-0.4 (-3.74%)

WVE Wave Life Sciences
$10.29 /

-0.4 (-3.74%)

12/15/20 H.C. Wainwright
Wave Life Sciences assumed with a Buy at H.C. Wainwright
11/20/20 Mizuho
Wave Life Sciences price target lowered to $19 from $21 at Mizuho
10/22/20 RBC Capital
Wave Life Sciences initiated with a Sector Perform at RBC Capital
09/22/20 Truist
Wave Life Sciences price target raised to $27 from $20 at Truist
WVE Wave Life Sciences
$10.29 /

-0.4 (-3.74%)

  • 23
    Sep
WVE Wave Life Sciences
$10.29 /

-0.4 (-3.74%)

Upgrade
Knight-Swift upgraded to Buy on 'robust' demand at BofA » 07:09
03/04/21
03/04
07:09
03/04/21
07:09
KNX

Knight-Swift

$45.27 /

+0.76 (+1.71%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KNX Knight-Swift
$45.27 /

+0.76 (+1.71%)

KNX Knight-Swift
$45.27 /

+0.76 (+1.71%)

06:58 Today BofA
Knight-Swift upgraded to Buy from Neutral at BofA
01/14/21 Citi
Knight-Swift price target raised to $48 from $46 at Citi
01/07/21 Wolfe Research
Knight-Swift downgraded to Peer Perform from Outperform at Wolfe Research
12/04/20
Evercore starts trucking coverage with preference for Old Dominion, Saia
KNX Knight-Swift
$45.27 /

+0.76 (+1.71%)

KNX Knight-Swift
$45.27 /

+0.76 (+1.71%)

Earnings
Shift4 Payments sees FY21 revenue $1.1B-$1.2B, consensus $1.08B » 07:09
03/04/21
03/04
07:09
03/04/21
07:09
FOUR

Shift4 Payments

$71.06 /

-4.24 (-5.63%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

01/06/21 Wolfe Research
Shift4 Payments downgraded to Peer Perform from Outperform at Wolfe Research
01/06/21 BofA
Shift4 Payments double-downgraded to Underperform from Buy at BofA
12/21/20
Fly Intel: Top five analyst initiations
12/21/20 Piper Sandler
Shift4 Payments initiated with an Overweight at Piper Sandler
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

  • 03
    Dec
  • 11
    Sep
  • 05
    Jun
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

Upgrade
J.B. Hunt upgraded to Buy on 'robust' demand at BofA » 07:08
03/04/21
03/04
07:08
03/04/21
07:08
JBHT

J.B. Hunt

$152.57 /

+1.7 (+1.13%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

06:58 Today BofA
J.B. Hunt upgraded to Buy from Neutral at BofA
01/26/21 Susquehanna
J.B. Hunt downgraded to Neutral from Positive at Susquehanna
01/26/21 Susquehanna
J.B. Hunt downgraded to Neutral from Positive at Susquehanna
01/21/21 Deutsche Bank
J.B. Hunt price target raised to $146 from $139 at Deutsche Bank
JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

JBHT J.B. Hunt
$152.57 /

+1.7 (+1.13%)

Hot Stocks
Bombardier targets 2025 total revenues about $7.5B » 07:08
03/04/21
03/04
07:08
03/04/21
07:08
BDRBF

Bombardier

$0.00 /

+ (+0.00%)

Targets 2025 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

02/16/21 Cowen
Bombardier downgraded to Underperform from Market Perform at Cowen
02/16/21 Scotiabank
Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank
02/12/21 National Bank
Bombardier price target lowered to C$0.70 from C$0.80 at National Bank
02/12/21 BMO Capital
Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

Upgrade
U.S. Xpress Enterprises upgraded to Buy from Underperform at BofA » 07:07
03/04/21
03/04
07:07
03/04/21
07:07
USX

U.S. Xpress Enterprises

$10.32 /

+0.47 (+4.77%)

BofA analyst Ken Hoexter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
USX U.S. Xpress Enterprises
$10.32 /

+0.47 (+4.77%)

USX U.S. Xpress Enterprises
$10.32 /

+0.47 (+4.77%)

07:02 Today BofA
Correction: U.S. Xpress Enterprises upgraded to Buy from Underperform at BofA
11/23/20 BofA
BofA cuts three truckers to Neutral, double downgrades U.S. Xpress
11/23/20 BofA
U.S. Xpress Enterprises downgraded to Underperform from Buy at BofA
10/15/20 Stifel
U.S. Xpress Enterprises upgraded to Buy amid tight spot market at Stifel
USX U.S. Xpress Enterprises
$10.32 /

+0.47 (+4.77%)

USX U.S. Xpress Enterprises
$10.32 /

+0.47 (+4.77%)

Hot Stocks
Bally's CEO seeing 'markedly stronger consumer demand' in January, February » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
BALY

Bally's

$60.69 /

-2.15 (-3.42%)

George Papanier,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

02/24/21 Truist
Bally's price target raised to $80 from $65 at Truist
02/09/21 Stifel
Bally's price target raised to $60 from $50 at Stifel
01/14/21 KeyBanc
KeyBanc bullish on Bally's, initiates with an Overweight
01/13/21 KeyBanc
Bally's initiated with an Overweight at KeyBanc
BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

BALY Bally's
$60.69 /

-2.15 (-3.42%)

Hot Stocks
Bombardier expects business jet deliveries to begin gradual recovery in 2021 » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
BDRBF

Bombardier

$0.00 /

+ (+0.00%)

Bombardier will host its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

02/16/21 Cowen
Bombardier downgraded to Underperform from Market Perform at Cowen
02/16/21 Scotiabank
Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank
02/12/21 National Bank
Bombardier price target lowered to C$0.70 from C$0.80 at National Bank
02/12/21 BMO Capital
Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

Earnings
Autolus Therapeutics reports 2020 EPS ($2.76), consensus ($2.67) » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
AUTL

Autolus Therapeutics

$6.44 /

-0.35 (-5.15%)

Reports 2020 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral with $9 target at JPMorgan
01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral from Overweight at JPMorgan
01/07/21 Truist
Autolus Therapeutics price target lowered to $15 from $30 at Truist
01/07/21 Mizuho
Autolus Therapeutics price target lowered to $18 from $24 at Mizuho
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

  • 10
    Feb
Earnings
Shift4 Payments reports Q4 adjusted EPS (5c), consensus 2c » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
FOUR

Shift4 Payments

$71.06 /

-4.24 (-5.63%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

01/06/21 Wolfe Research
Shift4 Payments downgraded to Peer Perform from Outperform at Wolfe Research
01/06/21 BofA
Shift4 Payments double-downgraded to Underperform from Buy at BofA
12/21/20
Fly Intel: Top five analyst initiations
12/21/20 Piper Sandler
Shift4 Payments initiated with an Overweight at Piper Sandler
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

  • 03
    Dec
  • 11
    Sep
  • 05
    Jun
FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

FOUR Shift4 Payments
$71.06 /

-4.24 (-5.63%)

Recommendations
Splunk price target lowered to $206 from $220 at Barclays » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
SPLK

Splunk

$143.31 /

-5.69 (-3.82%)

Barclays analyst Raimo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$143.31 /

-5.69 (-3.82%)

SPLK Splunk
$143.31 /

-5.69 (-3.82%)

06:39 Today Baird
Splunk price target lowered to $200 from $215 at Baird
05:58 Today Mizuho
Splunk price target lowered to $180 from $190 at Mizuho
03/03/21 Citi
Splunk assumed with a Neutral at Citi
03/02/21 RBC Capital
Splunk may see 'slight upside' in Q4 results, says RBC Capital
SPLK Splunk
$143.31 /

-5.69 (-3.82%)

SPLK Splunk
$143.31 /

-5.69 (-3.82%)

SPLK Splunk
$143.31 /

-5.69 (-3.82%)

SPLK Splunk
$143.31 /

-5.69 (-3.82%)

Hot Stocks
KKR to acquire Integrated Specialty Coverages, terms undisclosed » 07:06
03/04/21
03/04
07:06
03/04/21
07:06
KKR

KKR

$47.01 /

+0.55 (+1.18%)

Integrated Specialty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KKR KKR
$47.01 /

+0.55 (+1.18%)

KKR KKR
$47.01 /

+0.55 (+1.18%)

02/10/21 BMO Capital
KKR price target raised to $72 from $54 at BMO Capital
02/10/21 Wells Fargo
KKR price target raised to $54 from $46 at Wells Fargo
02/10/21 Citi
KKR price target raised to $61.50 from $52.50 at Citi
02/10/21 Barclays
KKR price target raised to $62 from $50 at Barclays
KKR KKR
$47.01 /

+0.55 (+1.18%)

  • 11
    Nov
KKR KKR
$47.01 /

+0.55 (+1.18%)

KKR KKR
$47.01 /

+0.55 (+1.18%)

Hot Stocks
Autolus Therapeutics announces key upcoming milestones » 07:05
03/04/21
03/04
07:05
03/04/21
07:05
AUTL

Autolus Therapeutics

$6.44 /

-0.35 (-5.15%)

Key Upcoming Clinical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral with $9 target at JPMorgan
01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral from Overweight at JPMorgan
01/07/21 Truist
Autolus Therapeutics price target lowered to $15 from $30 at Truist
01/07/21 Mizuho
Autolus Therapeutics price target lowered to $18 from $24 at Mizuho
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

  • 10
    Feb
Recommendations
Snowflake price target lowered to $270 from $295 at Barclays » 07:05
03/04/21
03/04
07:05
03/04/21
07:05
SNOW

Snowflake

$246.86 /

-23.73 (-8.77%)

Barclays analyst Raimo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

06:31 Today Citi
Snowflake price target lowered to $295 from $325 at Citi
06:10 Today Deutsche Bank
Snowflake upgraded to Buy with $300 price target at Deutsche Bank
06:03 Today Deutsche Bank
Snowflake upgraded to Buy from Hold at Deutsche Bank
01/21/21 Goldman Sachs
Snowflake initiated with a Neutral at Goldman Sachs
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

  • 16
    Sep
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

Hot Stocks
Soligenix announces progress in pre-clinical development of COVID-19 vaccine » 07:05
03/04/21
03/04
07:05
03/04/21
07:05
SNGX

Soligenix

$1.60 /

-0.045 (-2.74%)

Soligenix announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNGX Soligenix
$1.60 /

-0.045 (-2.74%)

SNGX Soligenix
$1.60 /

-0.045 (-2.74%)

12/23/20 Alliance Global Partners
Soligenix price target lowered to $5.75 from $7.25 at Alliance Global Partners
12/04/20 B. Riley Securities
B. Riley sees 100% upside in Soligenix, starts with Buy rating
12/04/20 B. Riley Securities
Soligenix initiated with a Buy at B. Riley Securities
07/28/20 Dawson James
Soligenix downgraded to Neutral from Buy at Dawson James
SNGX Soligenix
$1.60 /

-0.045 (-2.74%)

Earnings
Purple Innovation sees Q1 revenue $160M-$170M, consensus $176.46M » 07:04
03/04/21
03/04
07:04
03/04/21
07:04
PRPL

Purple Innovation

$36.25 /

-1.64 (-4.33%)

Sees Q1 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

01/12/21 B. Riley Securities
Purple Innovation price target raised to $41 from $20 at B. Riley Securities
01/12/21 Wedbush
Purple Innovation price target raised to $38 from $32 at Wedbush
12/16/20 Truist
Purple Innovation initiated with a Buy at Truist
12/16/20 Evercore ISI
Purple Innovation initiated with an Outperform at Evercore ISI
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

  • 10
    Sep
  • 15
    May
PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

PRPL Purple Innovation
$36.25 /

-1.64 (-4.33%)

Hot Stocks
Autolus Therapeutics expects cash to extend runway into 1H23 » 07:04
03/04/21
03/04
07:04
03/04/21
07:04
AUTL

Autolus Therapeutics

$6.44 /

-0.35 (-5.15%)

Autolus estimates that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral with $9 target at JPMorgan
01/29/21 JPMorgan
Autolus Therapeutics downgraded to Neutral from Overweight at JPMorgan
01/07/21 Truist
Autolus Therapeutics price target lowered to $15 from $30 at Truist
01/07/21 Mizuho
Autolus Therapeutics price target lowered to $18 from $24 at Mizuho
AUTL Autolus Therapeutics
$6.44 /

-0.35 (-5.15%)

  • 10
    Feb
Syndicate
Fiverr cancels $700M follow-on offering due to market conditions  07:04
03/04/21
03/04
07:04
03/04/21
07:04
FVRR

Fiverr

$241.45 /

-38.15 (-13.64%)

 
ShowHide Related Items >><<
FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

02/19/21 UBS
Fiverr price target raised to $205 from $190 at UBS
02/19/21 JMP Securities
Fiverr price target raised to $340 from $190 at JMP Securities
02/19/21 Citi
Fiverr price target raised to $350 from $270 at Citi
02/18/21 Needham
Fiverr price target raised to $335 at Needham following quarterly results
FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

  • 04
    Mar
  • 29
    May
FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

FVRR Fiverr
$241.45 /

-38.15 (-13.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.